BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8606 related articles for article (PubMed ID: 18088454)

  • 21. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
    Jia XH; Zhu LP; Li JC; Wang CC
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
    Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
    Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRAME gene expression in childhood acute lymphoblastic leukemia.
    Steinbach D; Viehmann S; Zintl F; Gruhn B
    Cancer Genet Cytogenet; 2002 Oct; 138(1):89-91. PubMed ID: 12419593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies.
    Greiner J; Ringhoffer M; Taniguchi M; Li L; Schmitt A; Shiku H; Döhner H; Schmitt M
    Int J Cancer; 2004 Feb; 108(5):704-11. PubMed ID: 14696097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.
    Tajeddine N; Louis M; Vermylen C; Gala JL; Tombal B; Gailly P
    Leuk Lymphoma; 2008 Jun; 49(6):1123-31. PubMed ID: 18452107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the
    Zhang F; Lu AD; Zuo YX; Ding MM; Jia YP; Zhang LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):543-549. PubMed ID: 35644195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of CD66c (CEACM6) in adult acute leukemia and its significance].
    Chen BG; Yan WH; Meng ZF; Guo ZM; Zhu M; Li BL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):370-3. PubMed ID: 17147224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
    Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of PRAME gene expression in childhood acute myeloid leukemia.
    Steinbach D; Hermann J; Viehmann S; Zintl F; Gruhn B
    Cancer Genet Cytogenet; 2002 Mar; 133(2):118-23. PubMed ID: 11943337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent aberration of FHIT gene expression in acute leukemias.
    Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T
    Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expression and clinical significance of early differentiation antigens in acute leukemia].
    Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms' Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival.
    Khateeb EE; Morgan D
    Open Access Maced J Med Sci; 2015 Mar; 3(1):57-62. PubMed ID: 27275197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.
    Cilloni D; Gottardi E; De Micheli D; Serra A; Volpe G; Messa F; Rege-Cambrin G; Guerrasio A; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Oct; 16(10):2115-21. PubMed ID: 12357365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of hTERT gene expression in acute leukemia children].
    Li X; Wang X; Li X; Liu B; Zhang Y; Liao Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):486-8. PubMed ID: 12910697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
    Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
    Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of MUC1 gene and MDR1 gene in non-M3 subtype acute leukemia and their correlations to clinical treatment efficacy].
    Li GW; Wang DN; Lin DJ; Li XD; Lin GZ; He Y; Lin Q; Huang RW
    Ai Zheng; 2005 Aug; 24(8):1011-4. PubMed ID: 16086884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype].
    Liu YR; Lai YY; Chang Y; Ruan GR; Qin YZ; Wang YZ; Zhu HH; Shi HX; Jiang B; Jiang H; Jiang Q; Hao L; Li JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1385-9. PubMed ID: 24370016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of eIF4E in patients with leukemia and its clinical significance].
    Zhu LF; Chen XJ; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):1-6. PubMed ID: 23484680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 431.